OxSyBio is a company that develops 3D printing techniques to produce tissue-like and functional tissues for medical research and clinical applications. Its tissues are comprised of 3-dimensional networks of lipid-coated aqueous droplets that display emergent functions. OxSyBio's technologies can be used by patients in the clinic for precision medicine and organ repair or replacement.
OxSyBio total Funding
OxSyBio latest funding size
Time since last funding
|2 years ago|
|IP Group Plc, Woodford Investment Management, Oxford University Innovation, Parkwalk Advisors|
|GBP||FY, 2016||FY, 2017||FY, 2018|
OxSyBio has 360 Twitter Followers. The number of followers has decreased 1.4% month over month and decreased 2.1% quarter over quarter
When was OxSyBio founded?
OxSyBio was founded in 2014.
Who are OxSyBio key executives?
OxSyBio's key executives are Sam Olof, Hagan Bayley and Hadrian Green.
Who are OxSyBio competitors?
Competitors of OxSyBio include Nightbalance, Allevi and Open Bionics.
Where is OxSyBio headquarters?
OxSyBio headquarters is located at 25 Walbrook, London.
Where are OxSyBio offices?
OxSyBio has offices in London, Didcot and Soham.
How many offices does OxSyBio have?
OxSyBio has 4 offices.
Receive alerts for 300+ data fields across thousands of companies